Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients-Reference-Cited by-同舟云学术

Balancing selected medication costs with total number of daily injections: a preference analysis of GnRH-agonist and antagonist protocols by IVF patients

Published:2012 Issue:1 Volume:10 Page:67
ISSN:1477-7827
Container-title:Reproductive Biology and Endocrinology
language:en
Short-container-title:Reprod Biol Endocrinol

Author:

Sills E,Collins Gary S,Salem Shala A,Jones Christopher A,Peck Alison C,Salem Rifaat D

Publisher

Springer Science and Business Media LLC

Subject

Developmental Biology,Endocrinology,Reproductive Medicine,Obstetrics and Gynaecology

Reference25 articles.

1. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)

2. An OHSS-Free Clinic by segmentation of IVF treatment

3. The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy

4. A detailed cost analysis of in vitro fertilization and intracytoplasmic sperm injection treatment

5. Supracervical hysterectomy versus total abdominal hysterectomy: perceived effects on sexual function

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Driving factors in treatment decision-making of patients seeking medical assistance for infertility: a systematic review;Human Reproduction Update;2024-02-01

2. Current options to lower the cost of in vitro fertilization: a comprehensive review;F&S Reviews;2023-01

3. Pregnancy Outcomes Following Letrozole Use in Frozen-thawed Embryo Transfer Cycles: A Systematic Review and Meta-analysis;Geburtshilfe und Frauenheilkunde;2020-08

4. The relative importance of genetic parenthood;Reproductive BioMedicine Online;2019-07

5. Lipidomic Components Alterations of Human Follicular Fluid Reveal the Relevance of Improving Clinical Outcomes in Women Using Progestin-Primed Ovarian Stimulation Compared to Short-Term Protocol;Medical Science Monitor;2018-05-21